1711 related articles for article (PubMed ID: 26086430)
21. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
Yin T; Wang L; Yin L; Zhou J; Huo M
Biomaterials; 2015 Aug; 61():10-25. PubMed ID: 25996409
[TBL] [Abstract][Full Text] [Related]
22. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells.
Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H
J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722
[TBL] [Abstract][Full Text] [Related]
23. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
24. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
25. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
Tam YT; Shin DH; Chen KE; Kwon GS
J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
[TBL] [Abstract][Full Text] [Related]
26. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
[TBL] [Abstract][Full Text] [Related]
28. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
[TBL] [Abstract][Full Text] [Related]
30. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
31. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
32. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
33. PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.
Shu X; Zhu Z; Cao D; Zheng L; Wang F; Pei H; Wen J; Yang J; Li D; Bai P; Tang M; Ye H; Peng A; Li W; Chen L
Colloids Surf B Biointerfaces; 2019 Oct; 182():110356. PubMed ID: 31319226
[TBL] [Abstract][Full Text] [Related]
34. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
[TBL] [Abstract][Full Text] [Related]
35. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
36. Polymerizable disulfide paclitaxel prodrug for controlled drug delivery.
Ding Y; Chen W; Hu J; Du M; Yang D
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():386-90. PubMed ID: 25280719
[TBL] [Abstract][Full Text] [Related]
37. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
[TBL] [Abstract][Full Text] [Related]
38. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel prodrug-encapsulated polypeptide micelles with redox/pH dual responsiveness for cancer chemotherapy.
Liu J; Zhang Y; Liu C; Jiang Y; Wang Z; Li X
Int J Pharm; 2023 Oct; 645():123398. PubMed ID: 37690658
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Targeting Micelles Based on Linear-Dendritic PEG-PTX
Zhang Y; Lu Y; Zhang Y; He X; Chen Q; Liu L; Chen X; Ruan C; Sun T; Jiang C
Mol Pharm; 2017 Oct; 14(10):3409-3421. PubMed ID: 28832164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
